跳至主要内容
临床试验/CTRI/2013/12/004257
CTRI/2013/12/004257招募中2 期

Validation of Unani Pharmacopoeial formulation- Habb-e- Shifa for symptomatic relief in patients of Nazla-e- HÄ?r (Common Cold)

Central Council for Research in Unani Medicine CCRUM New Delhi0 个研究点目标入组 540 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
540

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All subjects should meet the following criteria:
  • 1-Patients of either sex in the age group of 18-65
  • 2- Patients of Nazla-e- HÄ?r (Common Cold) presenting with recent onset of any of the following symptoms:
  • KhushÅ«na al-Halaq (Sore throat)
  • Buhha al-Sawt (Hoarseness of Voice)
  • â??UtÄ?s (Sneezing/ Nasal irritation)
  • SudÄ?â?? (Headache)
  • Suâ??Ä?l (Cough)
  • Runny nose
  • Iâ??yÄ? (Malaise)
  • Flushing of Face
  • With or without low grade fever ( <102 0F)

排除标准

  • Patients will be excluded if they meet any of the following criteria:
  • 1. Patients of acute or chronic lower respiratory tract infection like pneumonia, Bronchitis, Asthma and Bronchiectasis.
  • 2. Fever 102oF
  • 3. Known cases of any other acute illness
  • 4. Pregnant and lactating women
  • 5. Known case of Renal/ Hepatic/ Cardiac impairment or the ailment needs long term therapy

研究者

发起方
Central Council for Research in Unani Medicine CCRUM New Delhi

相似试验